May 1 |
Kymera Therapeutics Q1 2024 Earnings Preview
|
Apr 26 |
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
Apr 25 |
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
|
Apr 25 |
20 Counties with the Highest Cancer Rates in the US
|
Apr 25 |
Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2
|
Apr 8 |
Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting
|
Mar 21 |
Kymera Therapeutics: Advancing Into Phase 2 With Partner Sanofi - I Still Have Faith
|
Mar 8 |
Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting
|
Mar 5 |
Insider Sell: CFO Bruce Jacobs Sells 3,934 Shares of Kymera Therapeutics Inc (KYMR)
|
Mar 3 |
Analysts' Revenue Estimates For Kymera Therapeutics, Inc. (NASDAQ:KYMR) Are Surging Higher
|